Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) - Net Assets

Latest as of March 2026: CN¥2.40 Billion CNY ≈ $351.69 Million USD

Based on the latest financial reports, Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) has net assets worth CN¥2.40 Billion CNY (≈ $351.69 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥3.04 Billion ≈ $445.49 Million USD) and total liabilities (CN¥640.98 Million ≈ $93.79 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Shanghai Shenqi Pharmaceutical Investmen (600613) tangible net worth to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥2.40 Billion
% of Total Assets 78.95%
Annual Growth Rate 6.71%
5-Year Change 0.21%
10-Year Change -1.54%
Growth Volatility 120.3

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A - Net Assets Trend (1992–2025)

This chart illustrates how Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's net assets have evolved over time, based on quarterly financial data. See defensive interval ratio of Shanghai Shenqi Pharmaceutical Investmen to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (1992–2025)

The table below shows the annual net assets of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A from 1992 to 2025. For live valuation and market cap data, see Shanghai Shenqi Pharmaceutical Investmen market cap and net worth.

Year Net Assets Change
2025-12-31 CN¥2.40 Billion
≈ $350.83 Million		 -1.21%
2024-12-31 CN¥2.43 Billion
≈ $355.12 Million		 +1.52%
2023-12-31 CN¥2.39 Billion
≈ $349.81 Million		 +0.73%
2022-12-31 CN¥2.37 Billion
≈ $347.27 Million		 -0.81%
2021-12-31 CN¥2.39 Billion
≈ $350.10 Million		 +2.78%
2020-12-31 CN¥2.33 Billion
≈ $340.61 Million		 -12.54%
2019-12-31 CN¥2.66 Billion
≈ $389.47 Million		 +2.42%
2018-12-31 CN¥2.60 Billion
≈ $380.28 Million		 +2.70%
2017-12-31 CN¥2.53 Billion
≈ $370.30 Million		 +3.93%
2016-12-31 CN¥2.43 Billion
≈ $356.31 Million		 +6.52%
2015-12-31 CN¥2.29 Billion
≈ $334.49 Million		 +14.41%
2014-12-31 CN¥2.00 Billion
≈ $292.37 Million		 +10.26%
2013-12-31 CN¥1.81 Billion
≈ $265.15 Million		 +699.61%
2012-12-31 CN¥226.61 Million
≈ $33.16 Million		 +7.15%
2011-12-31 CN¥211.50 Million
≈ $30.95 Million		 +9.94%
2010-12-31 CN¥192.37 Million
≈ $28.15 Million		 +4.87%
2009-12-31 CN¥183.43 Million
≈ $26.84 Million		 -12.16%
2008-12-31 CN¥208.82 Million
≈ $30.56 Million		 +2.22%
2007-12-31 CN¥204.29 Million
≈ $29.89 Million		 +8.38%
2006-12-31 CN¥188.49 Million
≈ $27.58 Million		 +1.93%
2005-12-31 CN¥184.92 Million
≈ $27.06 Million		 +4.94%
2004-12-31 CN¥176.21 Million
≈ $25.79 Million		 +17.29%
2003-12-31 CN¥150.23 Million
≈ $21.98 Million		 +2.80%
2002-12-31 CN¥146.14 Million
≈ $21.38 Million		 -41.97%
2001-12-31 CN¥251.84 Million
≈ $36.85 Million		 -30.27%
2000-12-31 CN¥361.16 Million
≈ $52.85 Million		 +7.25%
1999-12-31 CN¥336.74 Million
≈ $49.28 Million		 -7.30%
1998-12-31 CN¥363.26 Million
≈ $53.16 Million		 -0.08%
1997-12-31 CN¥363.54 Million
≈ $53.20 Million		 +3.90%
1996-12-31 CN¥349.90 Million
≈ $51.20 Million		 +9.46%
1995-12-31 CN¥319.66 Million
≈ $46.78 Million		 -2.41%
1994-12-31 CN¥327.54 Million
≈ $47.93 Million		 +3.55%
1993-12-31 CN¥316.31 Million
≈ $46.29 Million		 +12.64%
1992-12-31 CN¥280.81 Million
≈ $41.09 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 3253.6% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings CN¥705.81 Million 30.42%
Other Components CN¥1.61 Billion 69.58%
Total Equity CN¥2.32 Billion 100.00%

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Competitors by Market Cap

The table below lists competitors of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A ranked by their market capitalization.

Company Market Cap
Maha Energy AB (publ)
ST:MAHA-A
 $331.81 Million
Baader Bank Aktiengesellschaft
F:BWB
 $331.82 Million
Vetropack Holding SA
SW:VETN
 $331.91 Million
ASYMCHEM LAB.(TIAN.)H YC1
F:7K90
 $331.92 Million
Masterwork Machinery
SHE:300195
 $331.71 Million
i3system Inc
KQ:214430
 $331.62 Million
Fiera Capital Corporation
TO:FSZ
 $331.60 Million
Xiamen Goldenhome Co Ltd
SHG:603180
 $331.59 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 2,363,038,500 to 2,320,333,058, a change of -42,705,442 (-1.8%).
  • Net income of 38,244,071 contributed positively to equity growth.
  • Dividend payments of 88,224,756 reduced retained earnings.
  • Other comprehensive income decreased equity by 252,053,942.
  • Other factors increased equity by 259,329,185.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income CN¥38.24 Million +1.65%
Dividends Paid CN¥88.22 Million -3.8%
Other Comprehensive Income CN¥-252.05 Million -10.86%
Other Changes CN¥259.33 Million +11.18%
Total Change CN¥- -1.81%

Book Value vs Market Value Analysis

This analysis compares Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.09x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 3.00x to 1.09x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1992-12-31 CN¥1.57 CN¥4.73 x
1993-12-31 CN¥1.75 CN¥4.73 x
1994-12-31 CN¥1.81 CN¥4.73 x
1995-12-31 CN¥1.76 CN¥4.73 x
1996-12-31 CN¥1.93 CN¥4.73 x
1997-12-31 CN¥2.01 CN¥4.73 x
1998-12-31 CN¥1.81 CN¥4.73 x
1999-12-31 CN¥1.82 CN¥4.73 x
2000-12-31 CN¥1.85 CN¥4.73 x
2001-12-31 CN¥1.36 CN¥4.73 x
2002-12-31 CN¥0.76 CN¥4.73 x
2003-12-31 CN¥0.78 CN¥4.73 x
2004-12-31 CN¥0.89 CN¥4.73 x
2005-12-31 CN¥0.94 CN¥4.73 x
2006-12-31 CN¥0.95 CN¥4.73 x
2007-12-31 CN¥1.04 CN¥4.73 x
2008-12-31 CN¥1.08 CN¥4.73 x
2009-12-31 CN¥0.93 CN¥4.73 x
2010-12-31 CN¥1.02 CN¥4.73 x
2011-12-31 CN¥1.09 CN¥4.73 x
2012-12-31 CN¥0.56 CN¥4.73 x
2013-12-31 CN¥3.73 CN¥4.73 x
2014-12-31 CN¥3.64 CN¥4.73 x
2015-12-31 CN¥4.53 CN¥4.73 x
2016-12-31 CN¥4.41 CN¥4.73 x
2017-12-31 CN¥4.56 CN¥4.73 x
2018-12-31 CN¥4.79 CN¥4.73 x
2019-12-31 CN¥4.99 CN¥4.73 x
2020-12-31 CN¥4.27 CN¥4.73 x
2021-12-31 CN¥4.38 CN¥4.73 x
2022-12-31 CN¥4.31 CN¥4.73 x
2023-12-31 CN¥4.51 CN¥4.73 x
2024-12-31 CN¥4.30 CN¥4.73 x
2025-12-31 CN¥4.34 CN¥4.73 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 1.65%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 1.96%
  • • Asset Turnover: 0.62x
  • • Equity Multiplier: 1.36x
  • Recent ROE (1.65%) is above the historical average (1.04%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1992 7.49% 22.20% 0.26x 1.30x CN¥-7.04 Million
1993 11.31% 19.75% 0.42x 1.35x CN¥4.08 Million
1994 9.15% 13.81% 0.44x 1.51x CN¥-2.74 Million
1995 6.99% 10.36% 0.43x 1.56x CN¥-9.47 Million
1996 4.03% 6.13% 0.44x 1.50x CN¥-20.57 Million
1997 2.69% 3.61% 0.46x 1.61x CN¥-26.15 Million
1998 1.21% 3.37% 0.15x 2.32x CN¥-28.38 Million
1999 1.99% 6.15% 0.22x 1.50x CN¥-25.95 Million
2000 2.03% 12.01% 0.11x 1.61x CN¥-26.26 Million
2001 -18.04% -118.79% 0.09x 1.69x CN¥-67.88 Million
2002 -75.74% -813.26% 0.04x 2.13x CN¥-116.50 Million
2003 -20.03% -115.65% 0.08x 2.07x CN¥-42.03 Million
2004 9.47% 19.82% 0.21x 2.27x CN¥-848.73K
2005 4.65% 11.14% 0.24x 1.76x CN¥-8.94 Million
2006 1.70% 4.64% 0.21x 1.73x CN¥-14.12 Million
2007 7.45% 20.91% 0.22x 1.59x CN¥-4.73 Million
2008 2.32% 6.30% 0.27x 1.38x CN¥-14.54 Million
2009 -14.32% -30.81% 0.32x 1.47x CN¥-40.29 Million
2010 3.26% 5.36% 0.48x 1.27x CN¥-11.71 Million
2011 9.17% 11.84% 0.61x 1.27x CN¥-1.58 Million
2012 35.81% 14.89% 1.97x 1.22x CN¥52.92 Million
2013 6.25% 12.00% 0.47x 1.12x CN¥-67.03 Million
2014 9.16% 13.93% 0.57x 1.15x CN¥-16.42 Million
2015 9.72% 13.61% 0.60x 1.20x CN¥-6.27 Million
2016 7.72% 11.39% 0.53x 1.27x CN¥-53.83 Million
2017 5.26% 7.47% 0.56x 1.26x CN¥-116.74 Million
2018 4.18% 5.73% 0.59x 1.23x CN¥-147.89 Million
2019 3.21% 4.36% 0.54x 1.36x CN¥-177.72 Million
2020 -14.98% -18.76% 0.59x 1.36x CN¥-568.94 Million
2021 2.97% 3.02% 0.73x 1.34x CN¥-164.81 Million
2022 2.09% 2.03% 0.71x 1.45x CN¥-184.20 Million
2023 2.44% 2.43% 0.71x 1.40x CN¥-176.54 Million
2024 3.02% 3.48% 0.66x 1.32x CN¥-164.92 Million
2025 1.65% 1.96% 0.62x 1.36x CN¥-193.79 Million

Industry Comparison

This section compares Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's net assets metrics with peer companies in the Drug Manufacturers - General industry.

Industry Context

  • Industry: Drug Manufacturers - General
  • Average net assets among peers: $3,454,789,497
  • Average return on equity (ROE) among peers: 9.06%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) CN¥2.40 Billion 7.49% 0.27x $331.76 Million
Zhejiang Int'L Group Co Ltd (000411) $172.72 Million 3.54% 3.43x $732.38 Million
Zhejiang Zhenyuan Share Co Ltd (000705) $1.39 Billion 4.40% 0.48x $308.51 Million
Hunan Jingfeng Pharmaceutical (000908) $329.66 Million 0.90% 1.55x $750.55 Million
Hubei Guangji Pharmaceutical Co Ltd (000952) $481.54 Million 6.36% 0.40x $302.41 Million
Yifan Xinfu Pharmaceutical Co Ltd (002019) $320.93 Million 6.38% 0.61x $1.73 Billion
Guangdong Jiaying Pharmaceutical Co Ltd (002198) $82.63 Million 26.76% 0.45x $247.30 Million
Sichuan Kelun Pharmaceutical Co Ltd (002422) $26.74 Billion 10.98% 0.40x $8.36 Billion
Chongqing Lummy Pharmaceutical (300006) $1.69 Billion 1.22% 0.84x $760.20 Million
Zhejiang Jolly Pharmaceutical Co Ltd (300181) $2.76 Billion 9.89% 0.32x $1.32 Billion
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) $582.91 Million 20.21% 0.05x $1.63 Billion

About Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A

SHG:600613 China Drug Manufacturers - General
Market Cap
$331.76 Million
CN¥2.27 Billion CNY
Market Cap Rank
#14437 Global
#4315 in China
Share Price
CN¥4.73
Change (1 day)
-0.21%
52-Week Range
CN¥4.73 - CN¥7.19
All Time High
CN¥24.35
Categories
Companies in China Drug Manufacturers - General
About

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fiel… Read more